The use of MDMA-assisted therapy for mental illnesses, particularly PTSD, is inching it’s way towards approval by the Federal Drug Administration in the United States. An earlier, relatively small study published in the Journal of Psychopharmacology in 2011 (of 20 patients) by the Multidisciplinary Association for Psychedelic Studies (MAPS) found that 83% of patients (10/12) receiving the […]